Market Access News | pharmaphorum

News

TrumpRx, BlinkRX, GoodRx – what's going on in DTC sales?

Possible implications of TrumpRx, the federal direct-to-consumer sales channel, are starting to emerge ahead of its scheduled launch next year.

News

UK and US agencies team up for medtech, AI regulation

The regulatory authorities in the UK and US have agreed to work more closely together on the regulation of medical technologies and AI.

News

Pharmacist shelving medicine in pharmacy

NHS could pay more for medicines under new plan

Changes to the threshold used by NICE to measure cost-effectiveness could be on the way as part of a plan that would raise NHS spending on medicines.

News

Woman collects medicine bottle from vending kiosk

Amazon to launch drug vending machines at One Medical sites

Amazon's latest bid to disrupt the healthcare market in the US will see the introduction later this year of electronic drug dispensing kiosks.

News

Regeneron's Libtayo stakes out new territory in skin cancer

Regeneron's Libtayo has become the first checkpoint inhibitor to be cleared by the FDA as an adjuvant treatment for cutaneous squamous cell carcinoma.

News

NICE finalises support for CSL's HAE therapy Andembry

CSL Behring's Andembry can be used to prevent recurrent attacks of HAE by the NHS, following finalised guidance from reimbursement authority NICE.

TrumpRx, BlinkRX, GoodRx – what's going on in DTC sales?

UK and US agencies team up for medtech, AI regulation

NHS could pay more for medicines under new plan

Amazon to launch drug vending machines at One Medical sites

Regeneron's Libtayo stakes out new territory in skin cancer

NICE finalises support for CSL's HAE therapy Andembry

Lilly UK recruits ex-England cricketer as obesity champion

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks